Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists

By Joos G.F.   De Swert K.O.   Pauwels R.A.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 239-250

Elsevier

Access to resources Recommend Favorite

The tachykinin NK 1 receptor is crucial for the development of non-atopic airway inflammation and hyperresponsiveness

By van der Kleij H.P.M.   Kraneveld A.D.   Redegeld F.A.M.   Gerard N.P.   Morteau O.   Nijkamp F.P.  

European Journal of Pharmacology, Vol. 476, Iss. 3, 2003-08 ,pp. : 249-255

Elsevier

Access to resources Recommend Favorite

Tachykinin NK 2 receptor antagonists decrease eicosanoid release in lung anaphylaxis

By Montuschi P.   Curro D.   Ciabattoni G.  

European Journal of Pharmacology, Vol. 313, Iss. 1, 1996-10 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

New Perspectives in the Modulation of the Eicosanoid Cascade in Inflammation

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 5, 2005-08 ,pp. : 391-402

Bentham Science Publishers

Access to resources Recommend Favorite

COX inhibitors for airway inflammation

By Malhotra Sanjay   Deshmukh Sangram Shesharao   Dastidar Sunanda Ghosh  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 195-207

Informa Healthcare

Access to resources Recommend Favorite